Pancreatic Cancer Research

ResearcherInha UniversityActive in the last 2 years

Soyeon Ko

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5004018975. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancer. Co-author DOI 10.3892/ijmm.2024.5458↗
  2. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer. Co-author DOI 10.1016/j.biopha.2023.114716↗
  3. Discovery of a novel NUAK1 inhibitor against pancreatic cancer. Co-author DOI 10.1016/j.biopha.2022.113241↗
  4. A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer. Co-author PMID 36225647↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyung Hee Jung · 4 shared papers, 2022–2025 · strength 0.65
  2. Ye Jin Cho · 3 shared papers, 2022–2025 · strength 0.50
  3. Soon‐Sun Hong · 2 shared papers, 2023–2025 · strength 0.37
  4. Soon‐Sun Hong · 2 shared papers, 2022 · strength 0.28
  5. Sungwoo Hong · 2 shared papers, 2022 · strength 0.28
  6. Minhee Park · 1 shared paper, 2025 · strength 0.22
  7. Ji Eun Lee · 1 shared paper, 2023 · strength 0.15
  8. Myeong-Seong Seo · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.